Cargando…

Are oxidized low-density lipoprotein and C-reactive protein markers of atherosclerosis in nephrotic children?

BACKGROUND: Lipid disorders are known to be linked to disturbance in oxidative reactions and play an important role in the progression and complications of idiopathic nephrotic syndrome (INS). AIMS: The aim of this study was to assess oxidized low-density lipoprotein (oxLDL), high-sensitive C-reacti...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rybi-Szumińska, A., Wasilewska, A., Michaluk-Skutnik, J., Osipiuk-Remża, B., Fiłonowicz, R., Zając, M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer London 2014
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4610997/ https://www.ncbi.nlm.nih.gov/pubmed/25056585 http://dx.doi.org/10.1007/s11845-014-1170-8

Ejemplares similares

Normal values for urine renalase excretion in children
por: Rybi–Szumińska, Agnieszka, et al.
Publicado: (2014)

Steroid-Resistant Nephrotic Syndrome Caused by NUP93 Pathogenic Variants
por: Wasilewska, Anna, et al.
Publicado: (2023)

Serum RANKL, osteoprotegerin (OPG), and RANKL/OPG ratio in nephrotic children
por: Wasilewska, Anna, et al.
Publicado: (2010)

Urine fibroblast growth factor 23 levels in hypertensive children and adolescents
por: Zając, Magdalena, et al.
Publicado: (2015)

Urinary excretion of renin and angiotensinogen in hypertensive children and adolescents
por: Zając, Magdalena, et al.
Publicado: (2019)

Protein Biomarkers in Chronic Kidney Disease in Children—What Do We Know So Far?
por: Rybi Szumińska, Agnieszka, et al.
Publicado: (2023)

Current Status of Protein Biomarkers in Urolithiasis—A Review of the Recent Literature
por: Lasota, Aleksandra, et al.
Publicado: (2023)

Oxidized low density lipoprotein, stem cells, and atherosclerosis
por: Yang, Hui, et al.
Publicado: (2012)

The Role of Oxidized Low-Density Lipoproteins in Atherosclerosis: The Myths and the Facts
por: Maiolino, Giuseppe, et al.
Publicado: (2013)

Mechanistic Insights into the Oxidized Low-Density Lipoprotein-Induced Atherosclerosis
por: Khatana, Chainika, et al.
Publicado: (2020)

The Urinary Concentration of Trefoil Factor 3 (TFF3) in the Term and Preterm Neonates
por: Kamianowska, Monika, et al.
Publicado: (2023)

Low-density lipoprotein particles in atherosclerosis
por: Qiao, Ya-Nan, et al.
Publicado: (2022)

Oxidation of Low-Density Lipoprotein by Iron at Lysosomal pH: Implications for Atherosclerosis
por: Satchell, Leanne, et al.
Publicado: (2012)

Soluble Lectin-Like Oxidized Low Density Lipoprotein Receptor-1 as a Biochemical Marker for Atherosclerosis-Related Diseases
por: Pirillo, Angela, et al.
Publicado: (2013)

Oxidized low-density lipoprotein as a biomarker of in vivo oxidative stress: from atherosclerosis to periodontitis
por: Itabe, Hiroyuki
Publicado: (2012)

Developing a Strategy for Interventional Molecular Imaging of Oxidized Low-Density Lipoprotein in Atherosclerosis
por: Pandey, Samata S., et al.
Publicado: (2017)

Porphyromonas gingivalis accelerates atherosclerosis through oxidation of high-density lipoprotein
por: Kim, Hyun-Joo, et al.
Publicado: (2018)

Low-Density Lipoprotein Cholesterol, Structural Atherosclerosis, and Functional Atherosclerosis in Older Japanese
por: Shimizu, Yuji, et al.
Publicado: (2022)

Cysteamine Decreases Low‐Density Lipoprotein Oxidation, Causes Regression of Atherosclerosis, and Improves Liver and Muscle Function in Low‐Density Lipoprotein Receptor–Deficient Mice
por: Ahmad, Feroz, et al.
Publicado: (2021)

Low-Density Lipoprotein-Reactive T Cells Regulate Plasma Cholesterol Levels and Development of Atherosclerosis in Humanized Hypercholesterolemic Mice
por: Gisterå, Anton, et al.
Publicado: (2018)

Cysteamine inhibits lysosomal oxidation of low density lipoprotein in human macrophages and reduces atherosclerosis in mice
por: Wen, Yichuan, et al.
Publicado: (2019)

High density lipoproteins and atherosclerosis: emerging aspects
por: Sala, Federica, et al.
Publicado: (2012)

High density lipoprotein mimicking nanoparticles for atherosclerosis
por: Chen, Jun, et al.
Publicado: (2020)

Favorable therapeutic efficacy of low‐density lipoprotein apheresis for nephrotic syndrome with impaired renal function
por: Muso, Eri, et al.
Publicado: (2021)

Low density lipoprotein and very low density lipoprotein are selectively bound by aggregated C-reactive protein
Publicado: (1982)

Rosuvastatin protects against oxidized low-density lipoprotein-induced endothelial cell injury of atherosclerosis in vitro
por: Geng, Jianan, et al.
Publicado: (2019)

Inhibition of T cell response to native low-density lipoprotein reduces atherosclerosis
por: Hermansson, Andreas, et al.
Publicado: (2010)

Low-Density Lipoproteins Oxidation and Endometriosis
por: Polak, Grzegorz, et al.
Publicado: (2013)

Umbilical Cord Blood Transplantation-associated Nephrotic Syndrome Successfully Treated by Low-density Lipoprotein Apheresis
por: Sugawara, Yuka, et al.
Publicado: (2016)

High-Density Lipoprotein, Lecithin: Cholesterol Acyltransferase, and Atherosclerosis
por: Ossoli, Alice, et al.
Publicado: (2016)

Do free radicals play causal role in atherosclerosis? Low density lipoprotein oxidation and vitamin E revisited
por: Niki, Etsuo
Publicado: (2011)

Attenuating lipid metabolism in atherosclerosis: The potential role of Anti-oxidative effects on low-density lipoprotein of herbal medicines
por: Duan, Huxinyue, et al.
Publicado: (2023)

Circulating Oxidized Low-Density Lipoproteins and Antibodies against Oxidized Low-Density Lipoproteins as Potential Biomarkers of Colorectal Cancer
por: Diakowska, Dorota, et al.
Publicado: (2015)

Low Density Lipoprotein-Containing Circulating Immune Complexes: Role in Atherosclerosis and Diagnostic Value
por: Sobenin, Igor A., et al.
Publicado: (2014)

Urinary MMP-9/NGAL Ratio as a Potential Marker of FSGS in Nephrotic Children
por: Korzeniecka-Kozerska, Agata, et al.
Publicado: (2013)

High-Density Lipoprotein Suppresses Neutrophil Extracellular Traps Enhanced by Oxidized Low-Density Lipoprotein or Oxidized Phospholipids
por: Ohinata, Hitomi, et al.
Publicado: (2022)

On the pathogenesis of atherosclerosis: enzymatic transformation of human low density lipoprotein to an atherogenic moiety
Publicado: (1995)

The Dual Role of Low-Density Lipoprotein Receptor-Related Protein 1 in Atherosclerosis
por: Chen, Jiefang, et al.
Publicado: (2021)

Small, Dense Low-Density Lipoprotein-Cholesterol and Atherosclerosis: Relationship and Therapeutic Strategies
por: Jin, Xiao, et al.
Publicado: (2022)

Utility of Atherosclerosis Imaging in the Evaluation of High-Density Lipoprotein–Raising Therapies
por: Duivenvoorden, Raphaël, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_f1eub39o45l7kbgml5kuqhfllk